Respiri Limited
Peter Hildebrandt is the Chief Operating Officer at Respiri Limited, a company that supports respiratory health management by detecting wheeze, a typical symptom of asthma. Prior to this role, Peter served as Chief Executive Officer at Advanced Braking Technology Pty and eHatsystems Pty Ltd. Peter also has extensive experience in business development, marketing, and sales with companies like Dräger Safety Asia Pacific and Robert Bosch, specializing in automotive technology and mobility solutions. Peter holds a Master of Business Administration from AGSM @ UNSW Business School and has a background in economics and business administration.
This person is not in any teams
Respiri Limited
An RPM Business Augmented by R&D Respiri Limited (ASX:RSH, OTCQB:RSHUF) is a pioneering presence in the Remote Patient Monitoring (RPM) and MedTech sectors. The company uses its innovative respiratory technology with a disruptive business model as an RPM provider to offer the only RPM program for respiratory disorders. As a differentiated RPM provider, Respiri’s mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and, exclusively, respiratory disease. Respiri’s globally unique medical device and its Remote Patient Monitoring services empower healthcare organisations to take action from patient data when needed, not only when scheduled. Respiri is strategically positioned to revolutionise chronic disease management globally and is focused on the US market, where RPM services are reimbursed by Current Procedural Terminology (CPT) Code reimbursement.